Gapping up
In reaction to strong earnings/guidance: MGLN +8.3%, PHG +4.3%, QSR +2.5%, XCO +1.7%, HAE +0.7%
M&A news: XUE +48.4% (merges with Xiamen Insight Investment Co; whereby Insight will acquire Xueda stock for $5.50/ADS share in cash), TEVA +13.2% ( to acquire Allergan's (AGN) Generics business for $40.5 bln), BECN +8.5% (to acquire Roofing Supply Group from Clayton, Dubilier & Rice for $1.1 bln in cash and stock), AGN +6.6% (Teva (TEVA) to acquire Allergan's (AGN) Generics business for $40.5 bln), PRGO +4% (TEVA withdraws bid for MYL, paves way for MYL acq of PRGO), PLUG +1.7% (acquires HyPulsion from Air Liquide S.A (AIQUY) for $11.47 mln in stock)
Select metals/mining stocks trading higher: PAAS +3%, IAG +1.4%, TC +1.3%, CLF +1.2%, BHP +0.9%
Other news: MNOV +33.9% (FDA approval of the second phase 2 protocol for MN-001 in NASH which targets NASH patients with hypertriglyceridemia), TEVA +13.2% ( to acquire Allergan's (AGN) Generics business for $40.5 bln), AGN +6.6% (Teva (TEVA) to acquire Allergan's (AGN) Generics business for $40.5 bln), PRGO +4% (TEVA withdraws bid for MYL, paves way for MYL acq of PRGO), PSTI +3.9% (announces PLX Cells study results published in peer-reviewed scientific journal), SHPG +1.9% (still checking), SIG +1.6% (to join S&P 500), CTIC +1.6% (announced the appointment of Bruce J. Seeley as Executive Vice President and Chief Commercial Officer), RDHL +1.3% ( says that Salix Pharmaceuticals has confirmed it continues the development of RedHill's RHB-106 encapsulated bowel preparation)
Analyst comments: BOX +5.6% (upgraded to Overweight from Sector Weight at Keybanc/Pacific Crest), CAMT +4.2% (initiated with a Buy at Needham ), SSYS +3.3% (upgraded to Buy at Dougherty & Company), FTK +2.6% (upgraded to Perform from Underperform at Oppenheimer ), BIIB +1.3% (upgraded to Outperform from Mkt Perform at Bernstein), QCOM +0.7% (upgraded to Overweight from Equal-Weight at Morgan Stanley), AGCO +0.6% (upgraded to Neutral from Sell at Goldman)
In reaction to strong earnings/guidance: MGLN +8.3%, PHG +4.3%, QSR +2.5%, XCO +1.7%, HAE +0.7%
M&A news: XUE +48.4% (merges with Xiamen Insight Investment Co; whereby Insight will acquire Xueda stock for $5.50/ADS share in cash), TEVA +13.2% ( to acquire Allergan's (AGN) Generics business for $40.5 bln), BECN +8.5% (to acquire Roofing Supply Group from Clayton, Dubilier & Rice for $1.1 bln in cash and stock), AGN +6.6% (Teva (TEVA) to acquire Allergan's (AGN) Generics business for $40.5 bln), PRGO +4% (TEVA withdraws bid for MYL, paves way for MYL acq of PRGO), PLUG +1.7% (acquires HyPulsion from Air Liquide S.A (AIQUY) for $11.47 mln in stock)
Select metals/mining stocks trading higher: PAAS +3%, IAG +1.4%, TC +1.3%, CLF +1.2%, BHP +0.9%
Other news: MNOV +33.9% (FDA approval of the second phase 2 protocol for MN-001 in NASH which targets NASH patients with hypertriglyceridemia), TEVA +13.2% ( to acquire Allergan's (AGN) Generics business for $40.5 bln), AGN +6.6% (Teva (TEVA) to acquire Allergan's (AGN) Generics business for $40.5 bln), PRGO +4% (TEVA withdraws bid for MYL, paves way for MYL acq of PRGO), PSTI +3.9% (announces PLX Cells study results published in peer-reviewed scientific journal), SHPG +1.9% (still checking), SIG +1.6% (to join S&P 500), CTIC +1.6% (announced the appointment of Bruce J. Seeley as Executive Vice President and Chief Commercial Officer), RDHL +1.3% ( says that Salix Pharmaceuticals has confirmed it continues the development of RedHill's RHB-106 encapsulated bowel preparation)
Analyst comments: BOX +5.6% (upgraded to Overweight from Sector Weight at Keybanc/Pacific Crest), CAMT +4.2% (initiated with a Buy at Needham ), SSYS +3.3% (upgraded to Buy at Dougherty & Company), FTK +2.6% (upgraded to Perform from Underperform at Oppenheimer ), BIIB +1.3% (upgraded to Outperform from Mkt Perform at Bernstein), QCOM +0.7% (upgraded to Overweight from Equal-Weight at Morgan Stanley), AGCO +0.6% (upgraded to Neutral from Sell at Goldman)